Novus Robotics : Attorney Letter with Respect to Current Information

ROBERT C. LASKOWSKI

LAW OFFICE

520 S.W. YAMHILL

SUITE 600

PORTLAND, OREGON 97204-1329

TELEPHONE [phone] FACSIMILE 503-227-2980 EMAIL [e-mail]

March 25, 2022

OTC Markets Group, Inc.

304 Hudson Street

2nd Floor

New York, New York 10013

NOVUS ROBOTIC INC.

ANNUAL REPORT FOR THE FISCAL YEAR

ENDED DECEMBER 31, 2021

Ladies and Gentlemen:

You are entitled to rely on this letter in determining whether Novus Robotics Inc. ("Company") has made adequate current information publicly available within the meaning of Rule 144 (c)(2) under the Securities Act of 1933, as amended ("Securities Act").

The undersigned is a resident of the United States. Our office has been engaged by the Company to be its corporate and securities counsel. Our services include preparing or reviewing disclosure information and press releases, interfacing with the chief financial officer and independent accountants, and giving general legal advice to management.

Our letter relates to the laws of the United States, specifically the Securities Act and the corporate laws of the State of Nevada. The undersigned is member in good standing of the bar of the State of Oregon since 1971 and is permitted to practice before the Securities and Exchange Commission ("SEC") and the undersigned has not been prohibited from practice thereunder.

The undersigned is not currently, and in the past five years has not been, the subject of an investigation, hearing, or proceeding by the Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the Financial Industry Regulatory Authority, or any other federal, state or foreign regulatory agency.

The undersigned is not currently, and in the past five years has not been, suspended or barred from practicing in any state or jurisdiction, nor has the undersigned been charged in a civil or criminal case.

We have examined such corporate records and other documents and have asked such questions of law as we have considered necessary or appropriate for the purpose of writing this letter. We have relied on publicly available information from the Nevada Secretary of State and information obtained from the Company's officers and directors. We believe the sources relied upon are reliable.

The Company is not a reporting issuer under the Securities Exchange Act of 1934 ("Exchange Act") and, therefore, does not file periodic reports with the SEC. We have reviewed publicly available information relating to the Company posted through the OTC Disclosure and News Service and the Issuer's Annual Report and the Issuer's Annual Report for the fiscal year ended December 31, 2021 (collectively the "Information") posted through the OTC Disclosure and News Service on March 15, 2021.

The Information constitutes, in our opinion, adequate current public information concerning the Company's securities as of December 31, 2020 and is available within the meaning of Rule 144(c) (2) under the Securities Act. It includes all of the information that a broker-dealer would be required to obtain from the Company to publish a quotation for the securities under Rule 15c2-11 under the Exchange Act and complies as to form with the OTC Pink Basic Disclosure Guidelines v3 February 2021, which are located on the Internet atwww.otcmarkets.com and been posted through the OTC Disclosure & News Service.

The person responsible for the preparation of the Company's financial statements was Jaimie MacPherson of Lieu & MacPherson Financial Services Inc., Toronto, ON, Canada who is qualified to prepare the financial statements. The financial statements included with the Report have not been audited.

The Company's transfer agent is Manhattan Transfer Registrar Co. which is registered with the SEC. The method used to confirm the number of outstanding shares of common stock set forth in the Information Statement was to contact the transfer agent and receive written confirmation as to the number of outstanding shares.

The undersigned has (i) met with management and all of the directors namely, Berardino Paolucci, Drasko Karanovic and Beth Carey via video conference; (ii) reviewed the Information to be published by the Company through the OTC Disclosure and News Service and (iii) discussed the Information with management and a majority of the directors of the Company.

To the best of our knowledge, after inquiry of management and the directors of the Company, no officer, director or 5% or greater holder of the outstanding securities of the Company, or counsel, is currently under investigation by any federal or state regulatory authority for any violation of federal or states securities laws.

Neither the Issuer nor its predecessors, is or ever was a "shell company" as defined in Rule 405 of the Securities Act and 12b-2 of the Exchange Act.

We have not received, nor do we have an agreement to receive in the future, shares of the Company's stock, in payment of services.

No person other than OTC Markets Group, Inc. is entitled to rely on this letter. However, the undersigned hereby grants OTC Markets Group, Inc. full and complete permission and rights to publish this letter in the OTC Disclosure and News Service for viewing by the public and regulators.

Very truly yours,

Robert C. Laskowski /rcl